EVO Evotec

添加自选

3.410
-0.100-2.85%

收盘价 03/26 16:00 (美东)

3.410
0.0000.00%

盘后 16:05 (美东)

12.11亿总市值-6.57市盈率TTM

关于Evotec公司

Evotec 是一家药物发现合作公司，为制药和生物技术公司、学术机构、基金会和非营利组织提供解决方案。该公司在多种治疗领域提供服务，包括中枢神经系统疾病、糖尿病、炎症、肿瘤学、传染病和妇女健康。共享的研发部门，大约占销售额的80%，提供典型的按服务费用计费的药物发现和制造服务，以及基于其专有的、内部开发的资产的整合药物发现合作。Just-Evotec生物技术部门，大约占销售额的20%，提供生物技术的CDMO服务。截至2023年，该公司在欧洲和美国主要地区拥有超过5,000名员工和18个生产基地。

公司介绍

公司代码EVO

公司名称Evotec

发行价格21.75

成立日期1998

CEOMr. Christian Wojczewski, PhD

所属市场纳斯达克

员工数量5160

证券类型存托凭证

ADS转换比例2.0 : 1.0

年结日12-31

公司地址Manfred Eigen Campus,Essener Bogen 7

城市Hamburg

省份汉堡

国家德国

邮编22419

电话49-40-56081-0

网址http://evotec.com

董事高管

姓名
职务
年薪

Christian Wojczewski, PhD
Chief Executive Officer and Member of the Management Board
--

Laetitia Rouxel
Chief Financial Officer and Member of the Management Board
--

Aurelie Dalbiez
Chief People Officer and Member of the Management Board
--

Dr. Matthias Evers
Chief Business Officer and Member of the Management Board
--

Dr. Craig Johnstone
Chief Operating Officer and Member of the Management Board
--

Dr. Cord Dohrmann, PhD
Chief Scientific Officer and Member of the Management Board
--

Professor Dr. Iris Low-Friedrich
Chairman of the Supervisory Board
--

Roland Sackers
Vice Chairman of the Supervisory Board
--

Camilla Macapili Languille
Member of the Supervisory Board
--

Wesley P. Wheeler
Member of the Supervisory Board
--

Duncan McHale
Member of the Supervisory Board
--

Dr. Werner Lanthaler, PhD
Member of the Management Board
--

Dr. Constanze Ulmer-Eilfort
Member of the Supervisory Board
--

EVO Evotec

关于Evotec公司

公司介绍

董事高管

热门市场机会